Literature DB >> 16353375

Managing financial conflicts of interest in research.

Lisa A Bero1.   

Abstract

Evidence points to commercial sponsorship and personal financial gains for researchers leading to reporting more favorable results, tainting the climate of academic integrity, and negative public perceptions. Research institutions attempt to protect their own reputations and those of their faculty through establishing thresholds for reporting financial involvement and through committee review that may suggest that the sponsoring organization impose management practices designed to reduce conflicts or declining the funding. In one prominent university research system, a quarter of research projects reviewed required management because of conflicts of interest, the most common of these stemming from high "consulting fees" paid to researchers. The degree of understanding of policies regarding conflicts among researchers is uneven, and some regard these as private matters. Differences of opinion exist in the research community over whether disclosure of financial interests, although necessary, is sufficient to ensure a reasonable level of freedom from bias and to maintain public trust.

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  2005        PMID: 16353375

Source DB:  PubMed          Journal:  J Am Coll Dent        ISSN: 0002-7979


  3 in total

1.  Defining financial conflicts and managing research relationships: an analysis of university conflict of interest committee decisions.

Authors:  Elizabeth A Boyd; Lisa A Bero
Journal:  Sci Eng Ethics       Date:  2007-11-15       Impact factor: 3.525

2.  The tobacco industry's role in the 16 Cities Study of secondhand tobacco smoke: do the data support the stated conclusions?

Authors:  Richard L Barnes; S Katharine Hammond; Stanton A Glantz
Journal:  Environ Health Perspect       Date:  2006-12       Impact factor: 9.031

3.  External validation of a measurement tool to assess systematic reviews (AMSTAR).

Authors:  Beverley J Shea; Lex M Bouter; Joan Peterson; Maarten Boers; Neil Andersson; Zulma Ortiz; Tim Ramsay; Annie Bai; Vijay K Shukla; Jeremy M Grimshaw
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.